Londinia Opportunities Analyses - 05/23/2022 (GMT) UCB - 1H
Type: | Stocks |
Ticker: | UCB |
ISIN: | BE0003739530 |
- Europe Stocks
- Timeframe : 1H
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Analysis too old. There are no more charts available.
Additional analysis
Quotes
The UCB rating is 84.02 EUR. The price registered a decrease of -3.45% on the session and was between 83.46 EUR and 87.74 EUR. This implies that the price is at +0.67% from its lowest and at -4.24% from its highest.The Central Gaps scanner detects a bullish opening. A small advantage for buyers in the very short term.
Bullish opening
Type : Bullish
Timeframe : Openning
Here is a more detailed summary of the historical variations registered by UCB:
Near a new LOW record (1st january)
Type : Bearish
Timeframe : Weekly
New LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
Technical analysis of UCB in 1H shows a overall strongly bearish trend. 92.86% of the signals given by moving averages are bearish. The overall trend is supported by the strong bearish signals from short-term moving averages. The Central Indicators scanner does not detect any result on moving averages that would impact this trend.
An assessment of technical indicators shows a strong bearish signal.
Caution: the Central Indicators scanner currently detects an excess:
CCI indicator is oversold : under -100
Type : Neutral
Timeframe : 1 hour
Previous candle closed under Bollinger bands
Type : Neutral
Timeframe : 1 hour
Williams %R indicator is oversold : under -80
Type : Neutral
Timeframe : 1 hour
Pivot points : price is under support 3
Type : Neutral
Timeframe : 1 hour
Pivot points : price is under support 3
Type : Neutral
Timeframe : Weekly
An analysis of the price chart with the Central Patterns scanner (detector of chart patterns and resistances and supports) shows several results that can have an impact on the price change:
Near horizontal support
Type : Bullish
Timeframe : 1 hour
Support of channel is broken
Type : Bearish
Timeframe : 1 hour
The presence of a bullish Japanese candlestick pattern detected by Central Candlesticks that could cause a very short term rebound was also detected:
Bullish harami
Type : Bullish
Timeframe : 1 hour
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 66.07 | 76.35 | 83.94 | 84.02 | 88.38 | 94.77 | 98.64 |
Change (%) | -21.36% | -9.13% | -0.10% | - | +5.19% | +12.79% | +17.40% |
Change | -17.95 | -7.67 | -0.08 | - | +4.36 | +10.75 | +14.62 |
Level | Minor | Major | Major | - | Major | Intermediate | Intermediate |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 83.95 | 85.29 | 86.15 | 87.49 | 88.35 | 89.69 | 90.55 |
Camarilla | 86.42 | 86.62 | 86.82 | 87.02 | 87.22 | 87.42 | 87.63 |
Woodie | 83.72 | 85.17 | 85.92 | 87.37 | 88.12 | 89.57 | 90.32 |
Fibonacci | 85.29 | 86.13 | 86.65 | 87.49 | 88.33 | 88.85 | 89.69 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 81.62 | 84.10 | 85.56 | 88.04 | 89.50 | 91.98 | 93.44 |
Camarilla | 85.94 | 86.30 | 86.66 | 87.02 | 87.38 | 87.74 | 88.10 |
Woodie | 81.11 | 83.85 | 85.05 | 87.79 | 88.99 | 91.73 | 92.93 |
Fibonacci | 84.10 | 85.61 | 86.54 | 88.04 | 89.55 | 90.48 | 91.98 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 95.58 | 100.66 | 104.53 | 109.61 | 113.48 | 118.56 | 122.43 |
Camarilla | 105.94 | 106.76 | 107.58 | 108.40 | 109.22 | 110.04 | 110.86 |
Woodie | 94.98 | 100.36 | 103.93 | 109.31 | 112.88 | 118.26 | 121.83 |
Fibonacci | 100.66 | 104.08 | 106.19 | 109.61 | 113.03 | 115.14 | 118.56 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
RSI (14): | 23.69 | |
MACD (12,26,9): | -1.1800 | |
Directional Movement: | -29.40 | |
AROON (14): | -100.00 | |
DEMA (21): | 85.47 | |
Parabolic SAR (0,02-0,02-0,2): | 88.32 | |
Elder Ray (13): | -2.43 | |
Super Trend (3,10): | 86.51 | |
Zig ZAG (10): | 84.04 | |
VORTEX (21): | 0.7500 | |
Stochastique (14,3,5): | 3.91 | |
TEMA (21): | 85.11 | |
Williams %R (14): | -90.07 | |
Chande Momentum Oscillator (20): | -3.56 | |
Repulse (5,40,3): | -2.2200 | |
ROCnROLL: | 2 | |
TRIX (15,9): | -0.1200 | |
Courbe Coppock: | 6.19 |
MA7: | 87.87 | |
MA20: | 98.67 | |
MA50: | 103.62 | |
MA100: | 96.93 | |
MAexp7: | 85.33 | |
MAexp20: | 86.85 | |
MAexp50: | 89.06 | |
MAexp100: | 92.88 | |
Price / MA7: | -4.38% | |
Price / MA20: | -14.85% | |
Price / MA50: | -18.92% | |
Price / MA100: | -13.32% | |
Price / MAexp7: | -1.54% | |
Price / MAexp20: | -3.26% | |
Price / MAexp50: | -5.66% | |
Price / MAexp100: | -9.54% |
News
The last news published on UCB at the time of the generation of this analysis was as follows:
- UCB presents efficacy and safety results for zilucoplan and rozanolixizumab in generalized myasthenia gravis
- JAMA Neurology Publishes Phase 3 Study Results on the Efficacy and Safety of FINTEPLA® (fenfluramine) Oral Solution in Lennox-Gastaut Syndrome (LGS)
- UCB Showcases Strength of Broad Neurology Portfolio at 74th American Academy of Neurology (AAN) Annual Meeting
- FINTEPLA® (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)
- New Long-Term Complete Skin Clearance Data for Bimekizumab in Moderate to Severe Plaque Psoriasis Presented at the 2022 AAD Annual Meeting